Hyponatremic Cognitive Dysfunction Resulting from Drug-Drug-Gene Interaction between Sertraline and Cannabidiol in an Intermediate CYP2C19 Metabolizer Patient

Background: Pharmacogenomics (PGx) can provide more precision in determining causation of adverse drug reactions (ADRs) from drug-drug-gene interaction clinical application. Case Summary: Patient was an intermediate CYP2C19 metabolizer on stable therapy taking a low but therapeutic dose of sertralin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanan, Jade Camara, Crosby, Sheena, Schuh, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2022
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815864/
https://www.ncbi.nlm.nih.gov/pubmed/36627907
http://dx.doi.org/10.24926/iip.v13i3.4890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815864/
https://www.ncbi.nlm.nih.gov/pubmed/36627907
http://dx.doi.org/10.24926/iip.v13i3.4890

Ejemplares similares